InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -61.15% |
| Q3 2025 | -35699.18% |
| Q2 2025 | 37.11% |
| Q1 2025 | 46.70% |
| Q4 2024 | -34.32% |
| Q3 2024 | 37.70% |
| Q2 2024 | -21.51% |
| Q1 2024 | 3.50% |
| Q4 2023 | 75.66% |
| Q3 2023 | -466.54% |
| Q2 2023 | 77.60% |
| Q1 2023 | 51.44% |
| Q4 2022 | 77.92% |
| Q3 2022 | 49.05% |
| Q2 2022 | -79.06% |
| Q1 2022 | 37.21% |
| Q4 2021 | -58.57% |
| Q3 2021 | 39.06% |
| Q2 2021 | 1.48% |
| Q1 2021 | -11.53% |
| Q4 2020 | -20.27% |
| Q3 2020 | 27.13% |
| Q2 2020 | -8.41% |
| Q1 2020 | 18.83% |
| Q4 2019 | 11.11% |
| Q3 2019 | 16.69% |
| Q2 2019 | -28.08% |
| Q1 2019 | -33.83% |
| Q4 2018 | 11.42% |
| Q3 2018 | 10.30% |
| Q2 2018 | -31.98% |
| Q1 2018 | -17.41% |
| Q4 2017 | 17.38% |
| Q3 2017 | 4.08% |
| Q2 2017 | -42.96% |
| Q1 2017 | -33.44% |
| Q4 2016 | -119.79% |
| Q3 2016 | 19.32% |
| Q2 2016 | -34.56% |
| Q1 2016 | 47.79% |